Internal Medicine · Baton Rouge, LA
NPI
1770506735
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1401 N Foster Dr
Baton Rouge, LA, 70806
Phone (225) 987-9000
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,775
156 services
Medicare patients, 2024
53
Average age 61
Drug cost, 2024
$8.4M
9,194 prescriptions
Company payments, 2025
$762
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael O Stuart was code 99213 (office e&m - established), 115 times for 52 patients. In total Michael O Stuart billed 156 services in 8 codes, and Medicare paid $4,775.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 115 | 52 | $35.71 | $4,106 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 32 | 26 | $9.72 | $311 |
By year: 2022 $7,363 for 127 services; 2023 $6,950 for 169 services; 2024 $4,775 for 156 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael O Stuart prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 723 prescriptions and refills. In total Michael O Stuart wrote 9,194 Medicare prescriptions that cost $8.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 723 | 727 | 81 | $2.8M |
| Atorvastatin Calcium Generic | 684 | 1,123 | 120 | $3,561 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 431 | 437 | 47 | $1.6M |
| Amlodipine Besylate Generic | 370 | 604 | 62 | $849 |
| Tivicay Dolutegravir Sodium | 293 | 293 | 37 | $780K |
| Gabapentin Generic | 260 | 329 | 39 | $2,316 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 208 | 210 | 38 | $6,839 |
| Rosuvastatin Calcium Generic | 203 | 386 | 37 | $1,830 |
| Dovato Dolutegravir Sodium/Lamivudine | 189 | 189 | 21 | $531K |
| Carvedilol Generic | 175 | 228 | 26 | $679 |
| Sertraline Hcl Generic | 162 | 248 | 30 | $799 |
| Jardiance Empagliflozin | 155 | 237 | 25 | $133K |
| Metoprolol Succinate Generic | 152 | 217 | 21 | $1,003 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 144 | 144 | 18 | $637K |
| Losartan Potassium Generic | 136 | 226 | 26 | $820 |
Brand drugs: 3,395 claims; generic drugs: 5,761 claims; opioid claims: 44.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael O Stuart $762 ($762 in general payments such as food, travel and fees) from 8 companies. The largest payer was ViiV Healthcare Company with $394.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.